NovelStem International Corp.

Name: NovelStem International Corp. standardized financial statements, quarterly
Creator: Listed

NSTMOTCCIK 912544Consumer discretionaryFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$34.9k, Q2 FY2026

Net income−$85.8k, Q2 FY2026

NovelStem International Corp., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Selling, general and administrative	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$k	(548)	(93.6)	(180)	(141)	(564)	(43.0)	(94.6)	(64.0)	(39.5)	(40.7)	(5.0)	(34.9)
Interest expense	$k	28.5	42.7	94.8	107	105	119	113	36.0	43.7	0.0	36.0	50.9
Income tax	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Net income	$k	(1,096)	52.7	(303)	(303)	(2,464)	(163)	(207)	2,754	(77.4)	(89.3)	(55.0)	(85.8)
Diluted EPS	$ per share	(0.02)	not reported	(0.01)	(0.01)	(0.05)	not reported	0.00	0.06	not reported	not reported	0.00	0.00
Basic EPS	$ per share	(0.02)	not reported	(0.01)	(0.01)	(0.05)	not reported	0.00	0.06	not reported	not reported	0.00	0.00

Balance sheet

Cash and equivalents$56.2k, Q2 FY2026

Shareholders' equity−$2.0m, Q2 FY2026

NovelStem International Corp., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$k	7.0	53.1	5.2	7.9	45.3	6.1	3.4	1.1	0.6	0.3	89.9	56.2
Current assets	$k	50.0	86.6	36.0	28.8	68.9	31.9	21.7	15.3	14.8	15.8	101	64.7
Total assets	$k	2,019	2,255	2,401	2,339	198	160	150	15.3	14.8	15.8	101	64.7
Current liabilities	$k	1,954	346	3,297	3,516	3,599	5,304	not reported	not reported	not reported	2,157	not reported	2,097
Total liabilities	$k	4,034	4,206	4,642	4,874	5,189	5,304	5,493	1,990	2,067	2,157	2,048	2,097
Current portion of debt	$k	1,833	not reported	2,851	3,037	3,118	4,059	4,161	1,239	1,264	1,295	1,328	1,362
Short-term borrowings	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$k	(2,015)	(1,952)	(2,241)	(2,535)	(4,990)	(5,144)	(5,343)	(1,975)	(2,052)	(2,142)	(1,947)	(2,032)

Cash flow

Operating cash flow−$33.6k, Q2 FY2026

NovelStem International Corp., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(72.4)	(78.9)	(72.9)	(97.3)	(62.6)	(39.2)	(43.7)	(66.8)	(31.0)	(26.2)	(139)	(33.6)
Capital expenditure	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Share repurchases	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)49.33m, Q2 FY2026

NovelStem International Corp., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	46.9	46.9	46.9	46.9	46.9	46.9	46.9	46.9	47.8	46.9	47.4	49.3

Shares outstanding: 49.33m at Aug 14, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. Listed shows no prices and gives no investment advice.